David R. Gandara, MD, discusses how EMPOWER-Lung 1’s findings in KRAS G12C-mutated disease should inform the design of combination trials. Poster sessions at WCLC 2026 detail how surgery, nursing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results